Asai N - Search Results

1

The Lung Microbiome during Health and Disease.

Yagi K, Huffnagle GB, Lukacs NW, Asai N. Yagi K, et al. Among authors: asai n. Int J Mol Sci. 2021 Oct 8;22(19):10872. doi: 10.3390/ijms221910872. Int J Mol Sci. 2021. PMID: 34639212 Free PMC article. Review.

2

COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males.

Fonseca W, Asai N, Yagi K, Malinczak CA, Savickas G, Johnson CC, Murray S, Zoratti EM, Lukacs NW, Li J, Schuler Iv CF. Fonseca W, et al. Among authors: asai n. Viruses. 2021 Dec 2;13(12):2415. doi: 10.3390/v13122415. Viruses. 2021. PMID: 34960684 Free PMC article.

3

Early-Life Lung and Gut Microbiota Development and Respiratory Syncytial Virus Infection.

Yagi K, Asai N, Huffnagle GB, Lukacs NW, Fonseca W. Yagi K, et al. Among authors: asai n. Front Immunol. 2022 Apr 4;13:877771. doi: 10.3389/fimmu.2022.877771. eCollection 2022. Front Immunol. 2022. PMID: 35444639 Free PMC article. Review.

4

COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review.

Asai N, Mikamo H. Asai N, et al. J Glob Antimicrob Resist. 2021 Dec;27:282-283. doi: 10.1016/j.jgar.2021.10.009. Epub 2021 Nov 4. J Glob Antimicrob Resist. 2021. PMID: 34742911 Free PMC article. Review. No abstract available.

5

The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy.

Asai N, Kato H, Mikamo H. Asai N, et al. Respir Investig. 2022 Jul;60(4):496-502. doi: 10.1016/j.resinv.2022.03.002. Epub 2022 Apr 4. Respir Investig. 2022. PMID: 35422403 Free PMC article. Review.

6

Pathophysiological mechanism of non-HIV Pneumocystis jirovecii pneumonia.

Asai N, Motojima S, Ohkuni Y, Matsunuma R, Nakashita T, Kaneko N, Mikamo H. Asai N, et al. Respir Investig. 2022 Jul;60(4):522-530. doi: 10.1016/j.resinv.2022.04.002. Epub 2022 Apr 29. Respir Investig. 2022. PMID: 35501264 Review.

7

The ATS/ERS/JRS/ALAT statement "IPF by HRCT" could predict acute exacerbation of interstitial lung disease in non-small cell lung cancer.

Asai N, Katsuda E, Hamanaka R, Kosaka K, Matsubara A, Nishimura M, Tanaka H, Yokoe N, Takahashi A, Yamaguchi E, Kubo A. Asai N, et al. Tumori. 2017 Jan 21;103(1):60-65. doi: 10.5301/tj.5000574. Epub 2016 Oct 22. Tumori. 2017. PMID: 27791236

8

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion.

Yokoe N, Katsuda E, Kosaka K, Hamanaka R, Matsubara A, Nishimura M, Tanaka H, Asai N, Takahashi A, Kawamura T, Ishiguchi T, Yamaguchi E, Kubo A. Yokoe N, et al. Among authors: asai n. Intern Med. 2017;56(14):1791-1797. doi: 10.2169/internalmedicine.56.7464. Epub 2017 Jul 15. Intern Med. 2017. PMID: 28717073 Free PMC article.

9

Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model.

Yamagishi Y, Mikamo H, Kato H, Nishiyama N, Asai N, Koizumi Y, Sakanashi D, Suematsu H, Matsuura K, Hagihara M. Yamagishi Y, et al. Among authors: asai n. J Infect Chemother. 2017 Jun;23(6):368-373. doi: 10.1016/j.jiac.2017.02.013. Epub 2017 Mar 23. J Infect Chemother. 2017. PMID: 28343752

10

Caspofungin versus micafungin in the incidence of hepatotoxicity in patients with normal to moderate liver failure.

Shibata Y, Hagihara M, Kato H, Kawasumi N, Hirai J, Nishiyama N, Asai N, Koizumi Y, Yamagishi Y, Matsuura K, Mikamo H. Shibata Y, et al. Among authors: asai n. J Infect Chemother. 2017 Jun;23(6):349-353. doi: 10.1016/j.jiac.2017.02.008. Epub 2017 Apr 18. J Infect Chemother. 2017. PMID: 28431933

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page